Figure 3个  Table 4个
    • No. cases (%) Total
      +++ ++ +
      RE (n = 26) 1 (3.85) 1 (3.85) 12 (46.15) 14 (53.85)
      Control (n = 16) 0 (0) 0 (0) 0 (0) 0 (0)
      Note: +++: Strongly positive; ++: Moderately positive; +: Weakly positive.

      Table 1.  Expression of EBV antigen in brain tissues of RE patients

    • Brain atrophy Non-atrophy Total
      EBV-positive cases 14 0 14
      EBV-negative cases 4 8 12
      Total 18 8 26
      Note: Fisher’s exact test: P = 0.001.

      Table 2.  Association between brain atrophy and EBV antigen expression in brain tissues of RE patients

    • No. cases (%) Total
      +++/++ +
      TLR3 RE 14 (53.85) 12 (46.15) 26 (100)
      Control 1 (6.25) 5 (31.25) 6 (37.5)
      TLR9 RE 8 (30.77) 18 (69.23) 26 (100)
      Control 2 (12.5) 4 (25) 6 (37.5)
      TRIF RE 4 (15.38) 10 (38.46) 14 (53.85)
      Control 2 (12.5) 4 (25) 6 (37.5)
      Note: RE group: n = 26; Control group: n = 16; Strongly positive: +++/++; Weakly positive: +.

      Table 3.  Expression of TLRs in brain tissues of RE patients

    • Brain atrophy cases Non-atrophy cases Total
      +++/++ 12 2 14
      + 6 6 12
      Total 18 8 26
      Note: Strongly positive: +++/++; Weakly positive: +; Fisher’s exact test: P = 0.090.

      Table 4.  Association between brain atrophy and TLR3 expression levels in brain tissues of RE patients